Viral infections remain a significant cause of morbidity and mortality following renal
transplantation. Although cytomegalovirus is the most common opportunistic pathogen seen …

The wide range of immunosuppressive therapies and protocols permits tailored planning of
the initial regimen according to the immunological risk status of individual patients. Pre …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Human immunodeficiency virus (HIV) is no longer a contraindication to transplantation. For
HIV-infected patients, HIV-infected deceased donors (HIVDD) could attenuate the organ …

Lack of an accepted definition for 'high immunological risk'hampers individualization of
immunosuppressive therapy after kidney transplantation. For recipient‐related risk factors for …

The persistence of chronic immune activation and oxidative stress in human
immunodeficiency virus (HIV)-infected, antiretroviral drug-treated individuals are major …

The prognosis of human immunodeficiency virus (HIV) infection has improved in recent
years with the introduction of antiretroviral treatment. While the frequency of AIDS-defining …

Kidney transplantation is now considered as a reasonable option for HIV‐infected patients
with end‐stage renal disease. We describe here a retrospective study conducted in five …

Reports of kidney transplantation (KTX) in recipients with hepatitis C virus (HCV+), human
immunodeficiency virus (HIV+) or coinfection often do not provide adequate adjustment for …

Randomized trials comparing autologous stem cell transplant (ASCT) to conventional
chemotherapy have demonstrated superior survival among HIV-negative ASCT patients with …